Cellulose sulfate - Polydex Pharmaceuticals/CONRAD
Alternative Names: UshercellLatest Information Update: 03 Feb 2015
At a glance
- Originator Polydex Pharmaceuticals
- Developer CONRAD
- Class Antivirals; Biopolymers; Contraceptives; Glucans
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Suspended Bacterial vaginosis; Pregnancy
- Discontinued Chlamydial infections; Gonorrhoea; HIV infections
Most Recent Events
- 31 Jul 2012 Cellulose sulfate - Polydex Pharmaceuticals/CONRAD is available for licensing as of 31 Jul 2012. http://www.polydex.com/
- 31 Dec 2010 Suspended - Clinical-Phase-Unknown for Pregnancy (Prevention) in Zimbabwe (Vaginal)
- 31 Dec 2010 Suspended - Phase-I for Pregnancy (Prevention) in Dominican Republic (Vaginal)